【24h】

Novel, de novo dysferlin gene mutations in a patient with Miyoshi myopathy

机译:小说,患有Miyoshi肌病的患者中的De Novo Dysferlin基因突变

获取原文
获取原文并翻译 | 示例
           

摘要

Miyoshi myopathy (MM) is an autosomal recessive distal muscular dystrophy caused by mutations in the dysferlin gene (DYSF), a 150-kb gene on chromosome 2p13 that contains 55 coding exons. Many patients with MM harbour mutations in the DYSF gene, and most of these mutations are inherited from the patients' parents. Recently, we encountered novel, de novo mutations in the DYSF gene in a patient with MM. DYSF gene analysis was performed by targeted next-generation sequencing, and we found that the patient had compound heterozygous mutations, including a de novo mutation (c.613C T) in exon 6 and a novel missense mutation (c.968T C) in exon 11. The novel missense mutation, predicted to be a disease-causing mutation or affecting protein function by MutationTaster and Polyphen2, confirmed the diagnosis. These findings provide important insights into the pathogenesis and inheritance of MM.
机译:Miyoshi肌病(mm)是一种由脓肿基因(DYSF)中的突变引起的常染色体隐性远端肌营养不良营养不良营养不良营养不良营养不良营养不良症,其染色体2p13上的150 kB基因含有55种编码外显子。 许多患有DYSF基因中的MM包裹突变的患者,并且大多数这些突变都是患者的父母。 最近,我们在患者中遇到了Dysf基因中的小说,DE Novo突变在患有MM的患者中。 通过靶向的下一代测序进行DYSF基因分析,并发现患者具有化合物的杂合酶突变,包括在外显子6和新的畸形突变中(C.968T&GT)中的Novo突变(C.613C& T)。 c)在外显子11.新的致畸突变预测是通过突变甾体和多酚2的引起疾病突变或影响蛋白质功能,证实了诊断。 这些调查结果对MM的发病机制和遗传提供了重要的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号